Olmesartan medoxomil and Intervertebral disc protrusion - a phase IV clinical study of FDA data

Summary:

Intervertebral disc protrusion is reported as a side effect among people who take Olmesartan medoxomil (olmesartan medoxomil), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Prednisone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Intervertebral disc protrusion when taking Olmesartan medoxomil. It is created by eHealthMe based on reports of 14,970 people who have side effects when taking Olmesartan medoxomil from the FDA, and is updated regularly.

What is Olmesartan medoxomil?

Olmesartan medoxomil has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 15,240 Olmesartan medoxomil users. Check the latest studies of Olmesartan medoxomil.

What is Intervertebral disc protrusion?

Intervertebral disc protrusion (spinal disc protrusion) is found to be associated with 1,531 drugs and 1,305 conditions by eHealthMe. Check the latest studies of Intervertebral disc protrusion.

On Jul, 05, 2026

14,970 people reported to have side effects when taking Olmesartan medoxomil.
Among them, 24 people (0.16%) have Intervertebral disc protrusion.

Could Olmesartan medoxomil cause Intervertebral disc protrusion?

Among these 24 people:

How long have people been on Olmesartan medoxomil when they have Intervertebral disc protrusion? *

What is the gender of people who have Intervertebral disc protrusion when taking Olmesartan medoxomil? *

female: 68.42 %
male: 31.58 %

What is the age of people who have Intervertebral disc protrusion when taking Olmesartan medoxomil? *

What are other drugs people take besides Olmesartan medoxomil? *

What are other side effects people have besides Intervertebral disc protrusion? *

Weight Decreased: 10 people, 41.67%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 9 people, 37.50%
Infusion Related Reaction: 8 people, 33.33%
Pain In Extremity: 7 people, 29.17%
Indigestion: 6 people, 25.00%
Headache (pain in head): 6 people, 25.00%
Ligament Sprain (ligament stretched): 5 people, 20.83%
Pneumonia: 5 people, 20.83%
Infection: 5 people, 20.83%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 20.83%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 50.00%
High Blood Cholesterol: 4 people, 16.67%
Herpes Zoster: 3 people, 12.50%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 12.50%
Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 12.50%
Hepatitis C: 2 people, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.33%
Cough: 2 people, 8.33%
Anaemia (lack of blood): 2 people, 8.33%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Olmesartan medoxomil and have Intervertebral disc protrusion?

- Check whether Intervertebral disc protrusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Olmesartan medoxomil:

Olmesartan medoxomil (15,240 reports)

Browse all side effects of Olmesartan medoxomil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intervertebral disc protrusion:

Intervertebral disc protrusion (1,531 drugs)

Browse all the conditions that are associated with Intervertebral disc protrusion:

Intervertebral disc protrusion (1,305 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on olmesartan medoxomil (the active ingredients of Olmesartan medoxomil) and Olmesartan medoxomil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.